Delivery Order SPE2DR25D1053-SPE2DR26FV262
- Not listed
- The Defense Logistics Agency awarded a $30,851.70 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 3, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $27,876.13 delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder (60-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of December 15, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,702.52 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by January 7, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder in a 60-dose configuration, with a ceiling value of $13,819.64. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This $3,552.68 firm fixed-price delivery order, which is not set-aside restricted, represents a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $2,053.06 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count package). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $8,416.98 delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder (60-count package). This is a firm fixed-price, non-competitive delivery order with a completion date of December 24, 2025, and performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with the...
- The Defense Logistics Agency awarded a delivery order valued at $2,142.18 to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 7, 2026, with performance at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order...
- The Defense Logistics Agency awarded a $4,036.34 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-dose units). This is a firm fixed price, non-set-aside contract with an ultimate completion date of December 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $21,179.80 delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in 60-dose units. This firm fixed-price delivery order is scheduled for completion by August 7, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside restrictions, reflecting AmerisourceBergen's qualification to compete...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV262Delivery Order
The Defense Logistics Agency awarded a $20,734.05 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder in a 60-dose configuration. This competitive, firm fixed-price contract will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by January 7, 2026. The award carries no set-aside designation, indicating it was competed on a full and open basis. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This comprehensive IDC serves as the vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing a broad range of specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. The Trelegy Ellipta product is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease, representing the type of specialty pharmaceutical products routinely supplied to military treatment facilities and veteran healthcare programs through this contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.7k | 1/5/26 |